ATE299187T1 - Modifizierter humaner granulozyten-kolonie stimulierenderfaktor sowie verfahren zur herstellung desselben - Google Patents

Modifizierter humaner granulozyten-kolonie stimulierenderfaktor sowie verfahren zur herstellung desselben

Info

Publication number
ATE299187T1
ATE299187T1 AT00942494T AT00942494T ATE299187T1 AT E299187 T1 ATE299187 T1 AT E299187T1 AT 00942494 T AT00942494 T AT 00942494T AT 00942494 T AT00942494 T AT 00942494T AT E299187 T1 ATE299187 T1 AT E299187T1
Authority
AT
Austria
Prior art keywords
csf
stimulating factor
colony stimulating
producing
human granulocyte
Prior art date
Application number
AT00942494T
Other languages
English (en)
Inventor
Se Chang Kwon
Sung Youb Jung
Sung Min Bae
Gwan Sun Lee
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36129291&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE299187(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Application granted granted Critical
Publication of ATE299187T1 publication Critical patent/ATE299187T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00942494T 1999-07-08 2000-07-07 Modifizierter humaner granulozyten-kolonie stimulierenderfaktor sowie verfahren zur herstellung desselben ATE299187T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1019990027418A KR100356140B1 (ko) 1999-07-08 1999-07-08 인간 과립구 콜로니 자극인자 변이체 및 이의 생산 방법
PCT/KR2000/000733 WO2001004329A1 (en) 1999-07-08 2000-07-07 Modified human granulocyte-colony stimulating factor and process for producing same

Publications (1)

Publication Number Publication Date
ATE299187T1 true ATE299187T1 (de) 2005-07-15

Family

ID=36129291

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00942494T ATE299187T1 (de) 1999-07-08 2000-07-07 Modifizierter humaner granulozyten-kolonie stimulierenderfaktor sowie verfahren zur herstellung desselben

Country Status (16)

Country Link
US (2) US20040224393A1 (de)
EP (1) EP1194575B2 (de)
JP (1) JP2003504069A (de)
KR (1) KR100356140B1 (de)
CN (1) CN1195859C (de)
AT (1) ATE299187T1 (de)
AU (1) AU757147C (de)
BR (2) BR0012265A (de)
CA (1) CA2378543C (de)
DE (1) DE60021188T3 (de)
DK (1) DK1194575T4 (de)
ES (1) ES2243275T5 (de)
NZ (1) NZ516476A (de)
PT (1) PT1194575E (de)
RU (1) RU2232772C2 (de)
WO (1) WO2001004329A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6831158B2 (en) 2000-01-10 2004-12-14 Maxygen Holdings Ltd. G-CSF conjugates
EP1425304B9 (de) 2001-07-11 2010-09-08 Maxygen, Inc. G-csf konjugate
EP1539960B1 (de) * 2002-09-09 2010-04-28 Hanall Pharmaceutical Co., Ltd. Protease-resistente modifizierte interferon alpha polypeptide
ATE544460T1 (de) 2003-10-24 2012-02-15 Nora Therapeutics Inc Zusammensetzungen und verfahren für eine gesunde schwangerschaft
US8338373B2 (en) 2003-10-24 2012-12-25 Nora Therapeutics, Inc. Method for reducing the risk of spontaneous abortion in a human female subject
US20090226397A1 (en) 2003-10-24 2009-09-10 Nora Therapeutics, Inc. Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
BRPI0611221A2 (pt) 2005-06-01 2010-08-24 Maxygen Holdings Ltd polipeptÍdeos de g-csf peguilados e mÉtodos de produÇço dos mesmos
DE102005033250A1 (de) 2005-07-15 2007-01-18 Bioceuticals Arzneimittel Ag Verfahren zur Reinigung von G-CSF
WO2009139784A1 (en) * 2008-05-13 2009-11-19 Nora Therapeutics, Inc. Human g-csf analogs and methods of making and using thereof
RU2519031C1 (ru) 2010-01-19 2014-06-10 Ханми Сайенс Ко., Лтд. Жидкие препаративные формы для длительно действующего конъюгата g-csf
RU2612884C2 (ru) * 2010-04-02 2017-03-13 Курна, Инк. Лечение заболеваний, связанных с колониестимулирующим фактором 3 (csf3), путем ингибирования природного антисмыслового транскрипта k csf3
KR101831300B1 (ko) 2010-10-29 2018-02-23 한미사이언스 주식회사 재조합 대장균으로부터 인간 과립구 콜로니 자극인자를 정제하는 방법
RU2467764C2 (ru) * 2011-01-12 2012-11-27 Государственное бюджетное образовательное учреждение дополнительного профессионального образования "Пензенский институт усовершенствования врачей" Министерства здравоохранения и социального развития Российской Федерации Способ лечения больных аутоиммунной хронической крапивницей с использованием внутривенного введения препарата "габриглобин"
KR101623906B1 (ko) 2014-07-23 2016-05-24 주식회사 이큐스앤자루 과립구 콜로니 자극인자 변이 단백질 또는 이의 트랜스페린 융합 단백질을 유효성분으로 포함하는 약학적 조성물
WO2016013725A1 (ko) * 2014-07-23 2016-01-28 주식회사 이큐스앤자루 과립구 콜로니 자극인자 변이 단백질 또는 이의 트랜스페린 융합 단백질을 유효성분으로 포함하는 약학적 조성물
AU2018215840A1 (en) 2017-02-03 2019-08-01 Hanmi Pharm. Co., Ltd. Long-Acting Conjugate Of A Physiologically Active Material And Use Thereof
US11684655B2 (en) 2019-05-31 2023-06-27 Spectrum Pharmaceuticals, Inc. Methods of treating neutorpenia using G-CSF protein complex
KR102375269B1 (ko) * 2021-01-27 2022-03-17 한미약품 주식회사 단백질 액상 제제 및 이의 제조방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810643A (en) * 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
EP0256843A1 (de) * 1986-08-11 1988-02-24 Cetus Corporation Expression von G-CSF, Muteine davon und deren Verwendung
US5714581A (en) * 1986-12-23 1998-02-03 Kyowa Hakko Kogyo Co., Ltd. Polypeptide derivatives of human granulocyte colony stimulating factor
US5362853A (en) * 1986-12-23 1994-11-08 Kyowa Hakko Kogyo Co., Ltd. Polypeptide derivatives of human granulocyte colony stimulating factor
JPH02104598A (ja) 1988-04-12 1990-04-17 Kirin Amgen Inc ヒト顆粒球コロニー刺激因子ポリペプチド誘導体
NZ236819A (en) * 1990-02-03 1993-07-27 Max Planck Gesellschaft Enzymatic cleavage of fusion proteins; fusion proteins; recombinant dna and pharmaceutical compositions
GB9107846D0 (en) * 1990-04-30 1991-05-29 Ici Plc Polypeptides
EP0626448A3 (de) * 1993-05-26 1998-01-14 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung und Reinigung von alpha-Interferon
US6476198B1 (en) * 1993-07-13 2002-11-05 The Scripps Research Institute Multispecific and multivalent antigen-binding polypeptide molecules
US5451660A (en) * 1993-12-13 1995-09-19 Genentech, Inc. Method for purifying polypeptides
NZ295673A (en) * 1994-11-01 1999-03-29 Wels Wilfried Nucleic acid transfer system using recombinant multi-domain proteins each domain having a different function
US6100070A (en) * 1995-10-05 2000-08-08 G. D. Searle & Co. G-CSF receptor agonists
KR100316347B1 (ko) * 1998-09-15 2002-08-27 한미약품(주) 대장균엔테로톡신ⅱ신호펩티드의변형체와인체성장호르몬의융합단백질을발현하는재조합미생물및그를이용한인체성장호르몬의제조방법
JP4873818B2 (ja) * 2000-05-16 2012-02-08 ボルダー バイオテクノロジー， インコーポレイテッド 遊離システイン残基を含有するタンパク質をリフォールディングする方法

Also Published As

Publication number Publication date
BR0012265A (pt) 2002-03-12
AU757147C (en) 2005-03-03
BRPI0012265B1 (pt) 2018-11-21
US7704709B2 (en) 2010-04-27
ES2243275T5 (es) 2009-12-02
AU5710600A (en) 2001-01-30
JP2003504069A (ja) 2003-02-04
WO2001004329A1 (en) 2001-01-18
US20080064066A1 (en) 2008-03-13
US20040224393A1 (en) 2004-11-11
ES2243275T3 (es) 2005-12-01
PT1194575E (pt) 2005-10-31
DK1194575T4 (da) 2009-12-07
CN1195859C (zh) 2005-04-06
KR20010009171A (ko) 2001-02-05
EP1194575A1 (de) 2002-04-10
DE60021188T3 (de) 2010-04-01
KR100356140B1 (ko) 2002-10-19
DE60021188D1 (de) 2005-08-11
EP1194575B2 (de) 2009-08-26
EP1194575A4 (de) 2002-10-24
CA2378543A1 (en) 2001-01-18
DK1194575T3 (da) 2005-10-17
AU757147B2 (en) 2003-02-06
BRPI0012265B8 (pt) 2021-05-25
NZ516476A (en) 2003-09-26
EP1194575B1 (de) 2005-07-06
CN1360636A (zh) 2002-07-24
DE60021188T2 (de) 2006-04-27
CA2378543C (en) 2010-05-18
RU2232772C2 (ru) 2004-07-20

Similar Documents

Publication Publication Date Title
ATE299187T1 (de) Modifizierter humaner granulozyten-kolonie stimulierenderfaktor sowie verfahren zur herstellung desselben
DE69334327D1 (de) Verfahren zur Herstellung sekretierter Proteine
ATE407210T1 (de) Verfahren zur herstellung von l-threonin durch enterobakteriaceae-stämmen mit verstärkter exprimierung der phob- und phor-gene
DE69739715D1 (de) Herstellungsverfahren von 1,3-propandiol durch rekombinante organismen
DE60030988D1 (de) Verfahren zur Herstellung Von L-Aminosäuren durch Erhöhung des zellulären NADPH
DE60238745D1 (de) Glucosamin und verfahren zur herstellung von glucosamin aus mikrobieller biomasse
ATE522612T1 (de) Tensid-tolerante cellulase sowie verfahren zur umwandlung davon
PL331351A1 (en) Novel strains of escherichia coli, methods of obtaining them and their application in l-treonin production fermentation processes
ATE414162T1 (de) Verfahren und materialien zur herstellung von glucosamin
DE60335195D1 (de) Mutante e. coli-appa-phytaseenzyme und natürliche varianten davon, solche phytaseenzyme codierende nukleinsäuren, diese enthaltende vektoren und wirtszellen und verfahren zur herstellung und verwendung davon
ATE404685T1 (de) Verfahren zur herstellung von l-aminosäuren mit stämmen der familie enterobacteriaceae in den das frur-gen deletiert worden ist
ATE326523T1 (de) Verfahren zur fermentativen herstellung von l- methionin
ATE70302T1 (de) Verfahren zur expression von alpha-1-antitrypsin in bakterien und dessen verwendung in therapeutischen zusammensetzungen sowie vektoren und bakterien fuer ein solches verfahren und deren herstellung.
ATE305973T1 (de) Verfahren zur herstellung von d-pantothensäure und/oder deren salzen
ATE522543T1 (de) Verfahren zur herstellung von reifem, rekombinantem milben-i-allergen
DE69031996D1 (de) Menschlicher rekombinanter plazentaler ribonuklease-inhibitor und verfahren zur herstellung
ATE451469T1 (de) In vivo-verfahren zur herstellung von proteinen, die nicht-konventionelle aminosäuren enthalten
ATE536411T1 (de) Verfahren zur herstellung von nichtaromatischen l-aminosäuren durch stämme aus der famile der enterobacteriaceae
CN116240253A (zh) 一种提高重组人源化胶原蛋白表达水平的发酵工艺
EP1126858A4 (de) Herstellung eines biologischen faktors und schaffung einer immunologisch vorteilhaften umgebung unter verwendung genetisch veränderter sertolizellen
ATE413456T1 (de) Verfahren zur herstellung von l-aminosäuren unter verwendung von stämmen der familie enterobacteriaceae
DE60321891D1 (de) Verfahren zur herstellung von l-threonin unter verwendung von stämmen der enterobacteriaceae familie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1194575

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 1194575

Country of ref document: EP